Diagnostic Prediction Model for De Novo Metastatic Breast Cancer
Recruiting · NCT07752238 · Observational (researchers observe without assigning treatment) · Lead sponsor: Markusovszky University Teaching Hospital os County Vas
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this observational study is to create a tool to estimate the risk of macroscopic distant tumor spread in women with newly diagnosed breast cancer. The main question it aims to answer is: • Can a model, which combines routine medical information collected at diagnosis, accurately predict if a patient has metastasis large enough to be found during systemic imaging? Researchers will review the past medical records of participants who were treated at a university hospital. Because this study looks at past data, participants will not be asked to do any new tasks, take new tests, or change their medical care.
Who can take part
Inclusion criteria
- Female sex, aged 18 years or older.
- Newly diagnosed invasive breast cancer.
- Case reviewed by the Multidisciplinary Tumour Board at the study site during the inclusion period (between October 1, 2018, and July 31, 2025).
- No history of prior or synchronous invasive malignancies, except for synchronous bilateral breast cancer.
- Intent for primary treatment and clinical management at the study site.
- Availability of longitudinal clinical records throughout the 12-month follow-up period or until death.
Exclusion criteria
- Absence of baseline systemic staging.
Where it is running
1 location listed.
- Markusovszky University Teaching Hospital - Szombathely, Vas County, Hungary